Advertisement

Roche's New Diabetes Drug Works Better Than Byetta

By Wall Street Journal Published at October 29, 2009 Views 376 Comments 2

Amy Tenderich

Roche's experimental diabetes drug taspoglutide worked better than a rival drug sold by Eli Lilly & Co. in lowering blood sugar, according to the results of a late stage study.

Read the full article at wsj.com Bullet-go~193754b0357b9819177de2890c558fa6

I like this I don't like this
  • Report Report as inappropriate
  • Share
    Email Email
    Print Print Twitter Twitter
    Facebook Facebook

Comments (2 comments)

Add your comment Reply Down
jayabee52
jayabee52 October 31, 2009 at 12:02 am   
I like this I don't like this Report as inappropriate

Decided to do some digging, and found the article without having to subscribel to WSJ & posted it.
jayabee52
jayabee52 October 30, 2009 at 11:38 pm   
I like this I don't like this Report as inappropriate

BUMMER! You have to get a subscription to the Wall Street Journal to see more than just the first few lines of the article!

Advertisement